StockTipsArenaBeta

BUY Sun Pharma Advanced Research Company Limited — Prakash Gaba

BUYSun Pharma Advanced Research Company Limited
Sun Pharma Advanced Research Company share price target & all analyst calls

byPrakash GabaHorizon: NA (inferred Swing (≤2wk))14 Oct 2026via CNBC Awaaz.

Entry₹194Inferred
Target₹200
Total upside +3.09% (call closed)
Stop loss₹190-2.06% risk
Exit₹19015 Oct 2026, 10:00 am
Stop-loss hit-2.06%
Follow Prakash Gaba for new calls(31% target hit, 283 closed calls)Get alertsWatch SPARC for new buy/sell callsGet alertsSee 229 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Oct, 7:36 pm IST
3 supporting0 opposing
Supports the BUY call (3)

Sun Pharma Advanced Research wins ₹28 crore CENVAT credit refund case in CESTAT

NewsCnbc-Tv18·4 Oct · 1w ago

(opens in new tab)

The CESTAT tribunal ruled in favor of the company, confirming its entitlement to a CENVAT credit refund of Rs 27.51 crore and dismissing the Revenue's appeal.

NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·4 Oct · 1w ago

(opens in new tab)

The CESTAT tribunal ruled in favor of the company, confirming its entitlement to a refund of accumulated CENVAT credit totaling Rs 27.51 crore, while dismissing the Revenue's appeal.

BSE · Company Update·4 Oct · 1w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sun Pharma Advanced Research Company

All analyst calls on Sun Pharma Advanced Research Company

More from Prakash Gaba

Every call and its outcome